Report Description:

Global Data’s clinical trial report, Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2014″ provides data on the Clostridium Difficile Infections (Clostridium Difficile Associated Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Clostridium Difficile Infections (Clostridium Difficile Associated Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

Browse Full Report with Toc Visit: http://www.acutemarketreports.com/report/clostridium-difficile-infections-clostridium-difficile-associated-disease-global-clinical-trials-review-h2-2015

The data book offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Clostridium Difficile Infections (Clostridium Difficile Associated Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Data’s team of industry experts.

Scope:

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Browse All Reports Of This Category: http://www.acutemarketreports.com/category/pharmaceutical-market

Reasons to buy:

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2

List of Tables 4

List of Figures 6

Introduction 8

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) 8

Report Guidance 8

Clinical Trials by Region 9

Clinical Trials and Average Enrollment by Country 10

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) to Infectious Disease Clinical Trials 17

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) to Infectious Disease Clinical Trials 20

Clinical Trials by Phase in E7 Countries 21

Clinical Trials in E7 Countries by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Clinical Trials by End Point Status 26

Unaccomplished Trials of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) 27

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials 32

Prominent Drugs 34

Latest Clinical Trials News on Clostridium Difficile Infections (Clostridium Difficile Associated Disease) 35

Oct 24, 2014: Metanome Selected as Metagenomics Provider for Seres Health Clinical Trial 35

Oct 09, 2014: Study Shows Rebiotix Microbiota-based Drug Candidate Targeted at Recurrent C. difficile Infection is Highly Effective 35

Oct 08, 2014: Cubist to Present New Data from Study of fidaxomicin in Children with Clostridium Difficile-Associated Diarrhea at IDWeek 2014 36

Sep 17, 2014: PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 36

Sep 08, 2014: Seres Health Presents Final Data for Study of SER-109 in Recurrent Clostridium difficile Infection at ICAAC 2014 Conference 37

Sep 08, 2014: Summit Presents New Positive Preclinical Efficacy Data On Its Selective C Difficile Antibiotic SMT19969 At ICAAC 2014 38

Sep 07, 2014: Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC 38

Sep 02, 2014: Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 39

Clinical Trial Profiles 40

Clinical Trial Overview of Top Companies 40

Cubist Pharmaceuticals, Inc. 40

Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 40

Sanofi 42

Clinical Trial Overview of Sanofi 42

Astellas Pharma Inc. 43

Clinical Trial Overview of Astellas Pharma Inc. 43

Synthetic Biologics, Inc. 44

Clinical Trial Overview of Synthetic Biologics, Inc. 44

Actelion Ltd 45

Clinical Trial Overview of Actelion Ltd 45

Pfizer Inc. 46

Clinical Trial Overview of Pfizer Inc. 46

Bio-K Plus International Inc. 47

Clinical Trial Overview of Bio-K Plus International Inc. 47

Romark Laboratories, L.C. 48

Clinical Trial Overview of Romark Laboratories, L.C. 48

Merck & Co., Inc. 49

Clinical Trial Overview of Merck & Co., Inc. 49

  1. I. du Pont de Nemours and Company 50

Clinical Trial Overview of E. I. du Pont de Nemours and Company 50

Clinical Trial Overview of Top Institutes / Government 51

Hadassah Medical Organization 51

Clinical Trial Overview of Hadassah Medical Organization 51

John D. Dingell VA Medical Center 52

Clinical Trial Overview of John D. Dingell VA Medical Center 52

Massachusetts General Hospital 53

Clinical Trial Overview of Massachusetts General Hospital 53

University of Pittsburgh 54

Clinical Trial Overview of University of Pittsburgh 54

Columbia University 55

Clinical Trial Overview of Columbia University 55

Boston Medical Center 56

Clinical Trial Overview of Boston Medical Center 56

Spectrum Health System 57

Clinical Trial Overview of Spectrum Health System 57

University of Rochester 58

Clinical Trial Overview of University of Rochester 58

University of Arkansas 59

Clinical Trial Overview of University of Arkansas 59

Duke University 60

Clinical Trial Overview of Duke University 60

Five Key Clinical Profiles 61

Download Free Request Sample: http://www.acutemarketreports.com/checkout/48488

Acute Market Reports:

About Us:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.  We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Contact Us:
Chris Paul
Sales Manager
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email: sales@acutemarketreports.com
Web: AcuteMarketReports